BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30616142)

  • 41. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer incidence in Nijmegen breakage syndrome is modulated by the amount of a variant NBS protein.
    Krüger L; Demuth I; Neitzel H; Varon R; Sperling K; Chrzanowska KH; Seemanova E; Digweed M
    Carcinogenesis; 2007 Jan; 28(1):107-11. PubMed ID: 16840438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NBS1, the Nijmegen breakage syndrome gene product, regulates neuronal proliferation and differentiation.
    Lee WT; Chang WH; Huang CH; Wu KJ
    J Neurochem; 2007 Jul; 102(1):141-52. PubMed ID: 17442057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiosensitivity in a newborn with microcephalia: A case report of Nijmegen breakage syndrome.
    Cakmak Genc G; Yilmaz B; Karakas Celik S; Aydemir C; Eroz R; Dursun A
    Birth Defects Res; 2024 May; 116(5):e2346. PubMed ID: 38761025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical variability and expression of the NBN c.657del5 allele in Nijmegen Breakage Syndrome.
    Lins S; Kim R; Krüger L; Chrzanowska KH; Seemanova E; Digweed M
    Gene; 2009 Nov; 447(1):12-7. PubMed ID: 19635536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation and characterization of a human iPSC line (UAMi004-A) from a patient with propionic acidemia due to defects in the PCCB gene.
    López-Márquez A; Alonso-Barroso E; Cerro-Tello G; Bravo-Alonso I; Arribas-Carreira L; Briso-Montiano Á; Navarrete R; Pérez-Cerdá C; Ugarte M; Pérez B; Desviat LR; Richard E
    Stem Cell Res; 2019 Jul; 38():101469. PubMed ID: 31132581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
    Martineau L; Racine V; Benichou SA; Puymirat J
    Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutations in the Nijmegen breakage syndrome gene in medulloblastomas.
    Huang J; Grotzer MA; Watanabe T; Hewer E; Pietsch T; Rutkowski S; Ohgaki H
    Clin Cancer Res; 2008 Jul; 14(13):4053-8. PubMed ID: 18593981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nijmegen breakage syndrome: the clearance pathway for mutant nibrin protein is allele specific.
    Salewsky B; Wessendorf P; Hirsch D; Krenzlin H; Digweed M
    Gene; 2013 May; 519(2):217-21. PubMed ID: 23458873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An integration-free iPSC line (SDQLCHi012-A) derived from a patient with inflammatory bowel disease- 28 carrying compound heterozygote mutations in IL10RA gene.
    Ma Y; Zhang H; Zhang S; Dong R; Yang X; Li Y; Guan J; Gai Z; Liu Y
    Stem Cell Res; 2019 Dec; 41():101577. PubMed ID: 31648101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of integration-free induced pluripotent stem cell lines derived from two patients with X-linked Alport syndrome (XLAS).
    Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
    Stem Cell Res; 2017 Dec; 25():291-295. PubMed ID: 29150092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
    Son D; Kang PJ; Yun W; You S
    Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Episomal plasmid-based generation of an iPSC line from an 83-year-old individual carrying the APOE4/4 genotype: i10984.
    Zulfiqar S; Fritz B; Nieweg K
    Stem Cell Res; 2016 Nov; 17(3):523-525. PubMed ID: 27789402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation.
    Gładkowska-Dura M; Dzierzanowska-Fangrat K; Dura WT; van Krieken JH; Chrzanowska KH; van Dongen JJ; Langerak AW
    J Pathol; 2008 Nov; 216(3):337-44. PubMed ID: 18788073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR1.
    Schröter F; Sleegers K; Van Cauwenberghe C; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):560-563. PubMed ID: 27789410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of the Nijmegen breakage syndrome 1 gene NBS1 by c-myc, p53 and coactivators mediates estrogen protection from DNA damage in breast cancer cells.
    Wan R; Wu J; Baloue KK; Crowe DL
    Int J Oncol; 2013 Feb; 42(2):712-20. PubMed ID: 23291854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
    Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
    Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Generation of induced pluripotent stem cell line (ZZUi0012-A) from a patient with Fahr's disease caused by a novel mutation in SLC20A2 gene.
    Zhang Q; Li Z; Sun H; Zhang S; Zhang J; Wang Y; Fang H; Xu Y
    Stem Cell Res; 2019 Mar; 35():101395. PubMed ID: 30776674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Establishment of a human iPSC line (SDQLCHi010-A) from a patient with optic nerve malformation carrying a heterozygous mutation in PAX6 gene.
    Zhang H; Ma Y; Yu S; Yang X; Li Y; Guan J; Dong R; Gai Z; Liu Y
    Stem Cell Res; 2019 Dec; 41():101611. PubMed ID: 31707209
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Derivation and characterization of integration-free iPSC line ISRM-UM51 derived from SIX2-positive renal cells isolated from urine of an African male expressing the CYP2D6 *4/*17 variant which confers intermediate drug metabolizing activity.
    Bohndorf M; Ncube A; Spitzhorn LS; Enczmann J; Wruck W; Adjaye J
    Stem Cell Res; 2017 Dec; 25():18-21. PubMed ID: 29035842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.